Piramal Group will be making an investment of Rs 500 crore over a period of three in years in Telangana for its pharma manufacturing expansion, among other things.
The proposed investment will be utilised to increase production capacities with creation of new manufacturing blocks, warehouse expansion and utility augmentation. Piramal Pharma currently has a manufacturing facility comprising three units multiple production blocks with a total reactor volume exceeding 1,000 kilo ltr.
Piramal Group is also keen on adding capacities through acquisitions in and around Hyderabad with an aim to increase active pharmaceutical ingredient (API) manufacturing. In addition, the company also plans to shift their pharmaceutical manufacturing operations from other states to a new location in Hyderabad, Telangana.